Literature DB >> 17890770

Influence of prostaglandin E2 on parturition in cattle.

G Hirsbrunner1, P Zanolari, H Althaus, J Hüsler, A Steiner.   

Abstract

A double-blinded, randomised, placebo-controlled field study of the influence of prostaglandin E2 (PGE2) on cattle at parturition was carried out. The extent of cervical opening and the intensity of labour were scored before administration of the compound and 10 minutes later; routine birth assistance was then continued by the veterinarian. Successful birth occurred more quickly in the cows treated with PGE2. The extent of cervical opening before the administration of the drug had a significant effect on the time to delivery, but the intensity of labour and a concomitant infusion of calcium did not have significant effects on this period. The less open the cervix before administration of the drug, the more the duration of parturition differed between the two groups, with the placebo group taking longer. A telephone follow-up inquiry found no significant differences between the cows postpartum; there were cases of mastitis and hypocalcaemia in both groups. The incidence of retained fetal membranes and the mortality of the calves were higher in the placebo group, but in neither case was the difference significant.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890770     DOI: 10.1136/vr.161.12.414

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  2 in total

Review 1.  Why Do So Many Calves Die on Modern Dairy Farms and What Can We Do about Calf Welfare in the Future?

Authors:  John F Mee
Journal:  Animals (Basel)       Date:  2013-11-04       Impact factor: 2.752

2.  Estradiol-induced immune suppression via prostaglandin E2 during parturition in bovine leukemia virus-infected cattle.

Authors:  Yamato Sajiki; Satoru Konnai; Tomohiro Okagawa; Naoya Maekawa; Shinya Goto; Junko Kohara; Atsushi Nitanai; Hirofumi Takahashi; Kentaro Kubota; Hiroshi Takeda; Shiro Murata; Kazuhiko Ohashi
Journal:  PLoS One       Date:  2022-03-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.